Continued Safety and Efficacy of Weekly Lonapegsomatropin (TransCon hGH) for up to Two Years in Children with Growth Hormone Deficiency (GHD)
2021
-
Correction
-
Source
-
Cite
-
Save
0
References
0
Citations
NaN
KQI